US Patent 9180162 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
Patent 9180162 was granted and assigned to Vical on November, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 10, 2014
0
Date of Patent
November 10, 2015
0
Patent Applicant
Patent Application Number
14176813
0
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9180162 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
